ArticlePharmaceutics2022

Discovery and SAR Study of Quinoxaline-Arylfuran Derivatives as a New Class of Antitumor Agents.

Dongmei Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.